Neonatal Intensive Care Monitoring

The use of the HeRO monitoring improves survival in very low birth weight neonates With HeRO Symphony we continue to improve upon the
capabilities of its forerunner the HeRO System with new advancements and capabilities Developed specifically for the neonatal infant,
the HeRO Heart Rate Observation System® represents the leading edge of what we see as a family of innovative diagnostic tools.

HeRo, an aid to assess the risk of sepsis in neonates

HeRO is intended to acquire, store, analyse, and report on ECG data collected from infants. HeRO is intended to be used by trained operators under the direct supervision of a licensed health care practitioner in a hospital neonatal or paediatric ICU environment. HeRO is intended to be used for the analysis of the variability in RR Intervals (heart rate) and to report measurements of the variability of heart rate data (HRV). The HRV measurements reported by HeRO are specialized in nature and intended to identify periods of transient decelerations and/or reduced baseline variability in the heart rate. HeRO is intended to provide specialized HRV measurements and may detect arrhythmias, that when combined with other risk factors, can be used as an aid in assessing the risk of sepsis in infants. The use of the HeRO monitoring improves survival in very low birth weight neonates.

Improving outcomes through monitoring

HeRO has been shown through clinical evidence to support improved outcomes and reduce cost in the neonatal intensive care unit. MPSC’s research programs continue to focus on the advancement of monitoring technologies that are proven effective through evidence-based medicine.